Elizabeth A. Czerepak
2016
In 2016, Elizabeth A. Czerepak earned a total compensation of $554.6K as Former Chief Financial Officer at PharmAthene.
Compensation breakdown
| Bonus | $87,000 |
|---|---|
| Option Awards | $167,000 |
| Salary | $290,000 |
| Other | $10,600 |
| Total | $554,600 |
Czerepak received $290K in salary, accounting for 52% of the total pay in 2016.
Czerepak also received $87K in bonus, $167K in option awards and $10.6K in other compensation.
Rankings
In 2016, Elizabeth A. Czerepak's compensation ranked 10,814th out of 14,075 executives tracked by ExecPay. In other words, Czerepak earned more than 23.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,814 out of 14,075 | 23rd |
Division Manufacturing | 4,201 out of 5,489 | 24th |
Major group Chemicals And Allied Products | 1,494 out of 1,895 | 21st |
Industry group Drugs | 1,201 out of 1,538 | 22nd |
Industry Pharmaceutical Preparations | 940 out of 1,176 | 20th |
Source: SEC filing on July 26, 2018.
Czerepak's colleagues
We found four more compensation records of executives who worked with Elizabeth A. Czerepak at PharmAthene in 2016.